Cargando…
BDNF-TrkB signaling-mediated upregulation of Narp is involved in the antidepressant-like effects of (2R,6R)-hydroxynorketamine in a chronic restraint stress mouse model
BACKGROUND: Preclinical studies have indicated that the ketamine metabolite (2R,6R)-hydroxynorketamine (HNK) is a rapid-acting antidepressant drug with limited dissociation properties and low abuse potential. However, its effects and molecular mechanisms remain unclear. In this work, we examined the...
Autores principales: | Ju, Lingsha, Yang, Jiaojiao, Zhu, Tingting, Liu, Panmiao, Yang, Jianjun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8922900/ https://www.ncbi.nlm.nih.gov/pubmed/35291971 http://dx.doi.org/10.1186/s12888-022-03838-x |
Ejemplares similares
-
BDNF receptor TrkB as the mediator of the antidepressant drug action
por: Casarotto, Plinio, et al.
Publicado: (2022) -
Prenatal Cocaine Exposure Upregulates BDNF-TrkB Signaling
por: Stucky, Andres, et al.
Publicado: (2016) -
Retraction: Prenatal Cocaine Exposure Upregulates BDNF-TrkB Signaling
Publicado: (2022) -
Is the History Repeated? Can (2R,6R)-Hydroxynorketamine be Another Antidepressant?
por: Chaki, Shigeyuki, et al.
Publicado: (2018) -
The Responsiveness of TrkB to BDNF and Antidepressant Drugs Is Differentially Regulated during Mouse Development
por: Di Lieto, Antonio, et al.
Publicado: (2012)